• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Etopophos (etoposide phosphate) powder for injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011


Summary View



  • Injection site reactions may occur during the administration of Etopophos. Closely monitor the infusion site for possible infiltration during drug administration. No specific treatment for extravasation reactions is known.


  • Local soft tissue toxicity has been reported following extravasation of Etopophos.